OrthoSpineNews

JUNE 10, 2025

CARLSBAD, CALIFORNIA, June 10, 2025 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF) , a pioneer in innovative spinal solutions, proudly announces that its proprietary SiLO Sacroiliac (SI) Joint Fusion System has been successfully used in over 2,500 procedures across the United States.

Joints 52

Joints Spine Clinic Treatment 52

OrthoSpineNews

APRIL 2, 2025

The study evaluates the biomechanical performance of Aurora Spine’s SiLO TFX MIS Sacroiliac Joint Fixation System compared to traditional posterolateral transosseous techniques. Trent Northcutt, President and CEO of Aurora Spine, expressed satisfaction with the outcomes of the biomechanical study conducted.

Spine 52

Spine Joints Clinic Treatment 52

ChiroUp

MARCH 13, 2025

Nearly half of the population experiences headaches, and an estimated 25% are cervicogenic headaches, i.e., stemming from dysfunction in the cervical spine. 1,2) While often overlooked, cervicogenic headaches can be just as debilitating as migraines, especially when compounded by cervical spine dysfunction.

Headache 130

Headache Treatment Spinal Manipulation Physical therapy 130

OrthoSpineNews

MARCH 25, 2025

March 25, 2025 (GLOBE NEWSWIRE) — Aurora Spine Corporation (Aurora Spine or the Company) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announced that the U.S. CARLSBAD, Calif.,

Spine 52

Spine Joints Pain Management Clinic 52

OrthoSpineNews

JANUARY 23, 2025

The US Bone and Joint Initiative identifies back discomfort as the leading cause of disability among Americans. In the United States, elective lumbar fusions rose by approximately 62%, from 122,679 in 2004 to 199,140 in 2015. The incidence of spine disorders rises with age and is most prevalent among those aged 60 to 69.

Clients 52

Clients Spine Treatment Clinic 52